These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6141338)

  • 41. "Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy.
    Yoshioka T; Shiraga H; Yoshida Y; Fogo A; Glick AD; Deen WM; Hoyer JR; Ichikawa I
    J Clin Invest; 1988 Nov; 82(5):1614-23. PubMed ID: 3183057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.
    Brenner BM; Meyer TW; Hostetter TH
    N Engl J Med; 1982 Sep; 307(11):652-9. PubMed ID: 7050706
    [No Abstract]   [Full Text] [Related]  

  • 43. Renal effects of intravenous amino acid administration in humans with and without renal disease: hormonal correlates.
    ter Wee PM
    Semin Nephrol; 1995 Sep; 15(5):426-32. PubMed ID: 8525145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma cAMP: a hepatorenal link influencing proximal reabsorption and renal hemodynamics?
    Bankir L; Martin H; Déchaux M; Ahloulay M
    Kidney Int Suppl; 1997 Jun; 59():S50-6. PubMed ID: 9185105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glomerular hypertension: cause and consequence of renal injury.
    Neuringer JR; Brenner BM
    J Hypertens Suppl; 1992 Dec; 10(7):S91-7. PubMed ID: 1291662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The hemodynamic basis of progressive renal disease.
    Dunn BR; Anderson S; Brenner BM
    Semin Nephrol; 1986 Jun; 6(2):122-38. PubMed ID: 3303239
    [No Abstract]   [Full Text] [Related]  

  • 47. Glomerular filtration rate in response to an acute protein load.
    von Herrath D; Saupe J; Hirschberg R; Rottka H; Schaefer K
    Blood Purif; 1988; 6(4):264-8. PubMed ID: 3207474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glomerular filtration rate is increased in man by the infusion of both D,L-3-hydroxybutyric acid and sodium D,L-3-hydroxybutyrate.
    Fioretto P; Trevisan R; Velussi M; Cernigoi A; De Riva C; Bressan M; Doria A; Pauletto N; Angeli P; De Donà C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):331-8. PubMed ID: 3298305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atrial natriuretic peptide and glomerular hyperfiltration during onset of spontaneous diabetes mellitus.
    Okwueze MI; Opgenorth TJ; von Geldern TW; Vari RC
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R572-7. PubMed ID: 8141417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of glucagon and glomerulopressin on the renal function of the dog.
    Uranga J; Fuenzalida R; Rapoport AL; del Castillo E
    Horm Metab Res; 1979 Apr; 11(4):275-9. PubMed ID: 457030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired renal response to a meat meal in insulin-dependent diabetes: role of glucagon and prostaglandins.
    Fioretto P; Trevisan R; Valerio A; Avogaro A; Borsato M; Doria A; Semplicini A; Sacerdoti D; Jones S; Bognetti E
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F675-83. PubMed ID: 2316671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients.
    Kontessis PA; Bossinakou I; Sarika L; Iliopoulou E; Papantoniou A; Trevisan R; Roussi D; Stipsanelli K; Grigorakis S; Souvatzoglou A
    Diabetes Care; 1995 Sep; 18(9):1233. PubMed ID: 8612436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The kidney failure of Bourneville's tuberous sclerosis: a new form of glomerular damage as a result of hyperfiltration?].
    Schillinger F; Montagnac R; Grapin JL; Birembaut P; Hopfner C
    Nephrologie; 1985; 6(5):219-23. PubMed ID: 4094635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Splanchnic and renal hemodynamic responses to intraportal infusion of glucagon.
    Premen AJ
    Am J Physiol; 1987 Dec; 253(6 Pt 2):F1105-12. PubMed ID: 3425720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasoregulatory hormones and the hyperfiltration of diabetes.
    Bank N; Lahorra MA; Aynedjian HS; Schlondorff D
    Am J Physiol; 1988 Feb; 254(2 Pt 2):F202-9. PubMed ID: 2449821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy.
    Asmar A; Simonsen L; Asmar M; Madsbad S; Holst JJ; Frandsen E; Moro C; Sorensen CM; Jonassen T; Bülow J
    Am J Physiol Endocrinol Metab; 2016 May; 310(9):E744-53. PubMed ID: 26956188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of dietary factors on the renal renin-angiotensin system.
    Wagner J; Stein G; Mann J; Ritz E
    Klin Wochenschr; 1992; 69 Suppl 29():35-8. PubMed ID: 1614190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of glomerular hyperfiltration by dopamine D(2)-like receptor blockade in experimental diabetes mellitus.
    Luippold G; Beilharz M; Mühlbauer B
    Nephrol Dial Transplant; 2001 Jul; 16(7):1350-6. PubMed ID: 11427624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of glucagon on glomerular filtration rate and urea and water excretion.
    Ahloulay M; Bouby N; Machet F; Kubrusly M; Coutaud C; Bankir L
    Am J Physiol; 1992 Jul; 263(1 Pt 2):F24-36. PubMed ID: 1636742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glomerular permselectivity to macromolecules in reflux nephropathy: microalbuminuria during acute hyperfiltration due to aminoacid infusion.
    Coppo R; Porcellini MG; Gianoglio B; Alessi D; Peruzzi L; Amore A; Bianchi M; Lace R; Cavalli G; Amprimo MC
    Clin Nephrol; 1993 Dec; 40(6):299-307. PubMed ID: 8299236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.